Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal–bolus regimens: insights from the PREDICTIVE study

By Hermansen Kjeld   Dornhorst Anne   Sreenan Seamus  

Current Medical Research and Opinion, Vol. 25, Iss. 11, 2009-11 ,pp. : 2601-2608

Informa Healthcare

Access to resources Recommend Favorite

Safety and efficacy of insulin detemir basal-bolus therapy in type 1 diabetes patients: 14-week data from the European cohort of the PREDICTIVE study

By Dornhorst Anne   Lüddeke Hans-Joachim   Honka Marek   Ackermann Ralf W.   Meriläinen Markus   Gallwitz Baptist   Sreenan Seamus    

Current Medical Research and Opinion, Vol. 24, Iss. 2, 2008-02 ,pp. : 369-376

Informa Healthcare

Access to resources Recommend Favorite

Intensification of insulin therapy in patients with type 2 diabetes mellitus: An algorithm for basal-bolus therapy

By Abrahamson Martin J.   Peters Anne  

Annals of Medicine, Vol. 44, Iss. 8, 2012-12 ,pp. : 836-846

Informa Healthcare

Access to resources Recommend Favorite

Insulin degludec improves long‐term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal‐bolus insulin therapy

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 2, 2015-02 ,pp. : 202-206

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biphasic vs basal bolus insulin regimen in Type 2 diabetes: a systematic review and meta‐analysis of randomized controlled trials

By  

DIABETIC MEDICINE, Vol. 32, Iss. 5, 2015-05 ,pp. : 585-594

John Wiley & Sons Inc

Access to resources Recommend Favorite